Michael Sherman

This inventor holds 15 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Curelab Oncology, Inc., Phylogency, Inc., Scientific Industries, Inc.. Active years: 1998-2021.

USPTO Granted Patents = 15 (Patent Applications = 8)

% Patents Active = 60.0

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 73(Granted Patents)

Location History:

Ma'ale Adumim, IL (2019)
Newton, MA (US) (1998 - 2021)

Company Filing History:

2 out of 2

Curelab Oncology, Inc.

Scientific Industries, Inc.

patents

4. 11 out of 834,350

Other

patents

Years Active: 1998-2021

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098098 - Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases (2021-08-24),

2. 10716837 - Methods and compositions relating to P62 for the treatment and prophylaxis of cancer (2020-07-21),

3. 10456788 - Apparatus for disruption of cell and tissue samples in multi-well plates (2019-10-29),

4. 9717781 - Methods and compositions relating to P62 for the treatment and prophylaxis of cancer (2017-08-01),

5. 9695392 - Apparatus for mixing and disruption of cell and tissue samples in vessels (2017-07-04),

6. 9693658 - Device and industrial package for storing, measuring and dispensing powder and granular substances (2017-07-04),

7. 9010987 - Method and an apparatus/universal combine for agitation of liquids (2015-04-21),

8. 8221300 - Holder for supporting test tubes side by side on a rack, and having a resilient mounting flange connecting the tubes to allow the holder to bend and fit into an angular slot of a centrifuge rotor (2012-07-17),

9. 7708946 - Device for protein detecting tests (2010-05-04),

10. 7204637 - Automated device for homogenization and resuspension of substances, disintegration of cells, disruption of tissues and centrifugation of these media (2007-04-17),

11. 6960430 - Screening methods for compounds useful in the regulation of cell proliferation (2005-11-01),

12. 6235245 - Device for mixing, resuspending, homogenizing and aeration of substances in test tubes (2001-05-22),

13. 6096711 - Hsp72 induction and applications (2000-08-01),

14. 5769538 - Mixer having means for periodically mechanically striking (1998-06-23),

15. 5707861 - Disintegrator of living cells (1998-01-13),

Title: Innovations and Contributions of Inventor Michael Sherman

Introduction

Michael Sherman is a notable inventor based in Newton, MA (US), recognized for his significant contributions to the field of medical research and treatment. With a total of 15 patents to his name, he has made substantial advancements in the understanding and treatment of various inflammatory diseases and cancer.

Latest Patents

Among his latest patents, Sherman has developed methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases. These novel p62 compositions are designed to modulate the expression of proinflammatory cytokines, osteogenic transcription factors, and bone resorptive factors. The applications of these compositions are extensive, targeting inflammatory diseases such as osteoporosis, obesity, type 2 diabetes, and neurodegenerative diseases, among others. Additionally, he has created methods and compositions relating to p62 for the treatment and prophylaxis of cancer, which include modified p62 compositions that enhance anti-cancer activity.

Career Highlights

Throughout his career, Michael Sherman has worked with various organizations, including Curelab Oncology, Inc. His innovative work has positioned him as a key figure in the development of therapeutic strategies aimed at combating serious health conditions.

Collaborations

Sherman has collaborated with notable individuals in his field, including Yury Sherman and Ilya Alexandrov, contributing to the advancement of research and innovation in medical treatments.

Conclusion

Michael Sherman’s contributions to the field of medical research through his patents and collaborations highlight his commitment to improving health outcomes. His work continues to influence the treatment of inflammatory diseases and cancer, showcasing the importance of innovation in medicine.